Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
Low MLR
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Twitter
Trials
VERI cancer hierarchy
x
x
x
x
Reset Filters
Low MLR
Renal Cell Carcinoma
Low MLR
Renal Cell Carcinoma
sorafenib
Sensitive: C3 – Early Trials
Cancer Control - 2 weeks (New C3)
sorafenib
Sensitive
:
C3
Cancer Control - 2wk
sorafenib
Sensitive: C3 – Early Trials
Cancer Control - 2 weeks
sorafenib
Sensitive
:
C3
Cancer Control - 2 weeks - (New C3)
Low MLR
Renal Cell Carcinoma
Low MLR
Renal Cell Carcinoma
sunitinib
Sensitive: C3 – Early Trials
Cancer Control - 2 weeks (New C3)
sunitinib
Sensitive
:
C3
Cancer Control - 2wk
sunitinib
Sensitive: C3 – Early Trials
Cancer Control - 2 weeks
sunitinib
Sensitive
:
C3
Cancer Control - 2 weeks - (New C3)
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
